PRINCE Polymeric ice nucleators as additives for novel freezing media to improve cryopreservation
- Coordinator
- Technische Universiteit Eindhoven, Netherlands
- Runs
- 1 April 2026 to 30 September 2027
- Status
- Running
- EU funding
- €150k
- Total cost
- —
- Partners
- 1 organisations in 1 countries
- Type
- European Research Council grant
- Grant agreement
- 101288730
What the project is doing
In the project's own words, from its summary on CORDIS.
Although cryopreservation would allow for the long-term storage of sensitive materials and biological samples, it is not commonpractice because success rates vary greatly between different samples. Improving the success of cryopreservation techniques willmake long-term storage more accessible across industries, clinics, and research institutes, enabling more effective use of patient-derivedmaterials and “back-ups” of crucial cell lines.
My ERC-consolidator grant project PROTECT focuses on the development of newice-interactive materials. While studying a group of well-defined ice-binders, I discovered a class of materials able to induceheterogeneous ice nucleation at the highest temperatures so far described for synthetic materials. Importantly, I demonstrated thatthis effect is still observable in sample volumes similar to those used for cryopreservation.
This discovery is of great significance sinceit has been shown that during cryopreservation, inducing ice nucleation at temperatures closer to 0°C improves the viability of cells,but so far, there are no viable methods available to control nucleation. By using this material class as an additive to currentcryopreservation media, it now becomes possible to control at what temperature ice nucleation will occur. Considering that currentcryopreservation approaches cannot control ice nucleation at scale yet, my discovery could fulfil a pressing need.
In this ERC PoC, Iwant to perform the key scientific steps that bring these materials closer to a commercially available additive for cryopreservation byoptimizing its (scalable) synthesis, through the technical validation of its effect on cardiomyocyte cryopreservation as showcaseexample, and with a feasibility study to identify the best route to commercial exploitation.
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Technische Universiteit Eindhoven | Eindhoven | Netherlands | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI